Cargando…
Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profile
Non-small cell lung cancer (NSCLC) is the second most prevalent type of cancer. With the current treatment regimens, the mortality rate remains high. Therefore, better therapeutic approaches are necessary. NSCLCs generally possess many genetic mutations and are well infiltrated by T cells (TIL), mak...
Autores principales: | De Groot, Rosa, Van Loenen, Marleen M., Guislain, Aurélie, Nicolet, Benoît P., Freen-Van Heeren, Julian J., Verhagen, Onno J.H.M., Van Den Heuvel, Michel M., De Jong, Jeroen, Burger, Patrick, Van Der Schoot, C.Ellen, Spaapen, Robbert M., Amsen, Derk, Haanen, John B. A. G., Monkhorst, Kim, Hartemink, Koen J., Wolkers, Monika C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791436/ https://www.ncbi.nlm.nih.gov/pubmed/31646094 http://dx.doi.org/10.1080/2162402X.2019.1648170 |
Ejemplares similares
-
T cells expanded from renal cell carcinoma display tumor-specific CD137 expression but lack significant IFN-γ, TNF-α or IL-2 production
por: van Asten, Saskia D., et al.
Publicado: (2021) -
Human T cells employ conserved AU‐rich elements to fine‐tune IFN‐γ production
por: Freen‐van Heeren, Julian J., et al.
Publicado: (2020) -
Time-dependent regulation of cytokine production by RNA binding proteins defines T cell effector function
por: Popović, Branka, et al.
Publicado: (2023) -
Effective generation of tumor-infiltrating lymphocyte products from metastatic non-small-cell lung cancer (NSCLC) lesions irrespective of location and previous treatments
por: Castenmiller, S.M., et al.
Publicado: (2022) -
Using CRISPR to enhance T cell effector function for therapeutic applications
por: Freen-van Heeren, Julian J.
Publicado: (2020)